0001178913-22-003079.txt : 20220812
0001178913-22-003079.hdr.sgml : 20220812
20220812160540
ACCESSION NUMBER: 0001178913-22-003079
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220812
DATE AS OF CHANGE: 20220812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CITRON SHIMON
CENTRAL INDEX KEY: 0001284150
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24431
FILM NUMBER: 221160020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Artemis Therapeutics, Inc.
CENTRAL INDEX KEY: 0001062128
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890]
IRS NUMBER: 841417774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 EAST 16TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10003
BUSINESS PHONE: 646-233-1454
MAIL ADDRESS:
STREET 1: 18 EAST 16TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10003
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK GLOBAL INNOVATIONS INC.
DATE OF NAME CHANGE: 20140305
FORMER COMPANY:
FORMER CONFORMED NAME: INKSURE TECHNOLOGIES INC.
DATE OF NAME CHANGE: 20050401
FORMER COMPANY:
FORMER CONFORMED NAME: INKSURE TECHNOLOGIES INC
DATE OF NAME CHANGE: 19980519
3
1
zk2228331.xml
X0206
3
2022-06-30
0
0001062128
Artemis Therapeutics, Inc.
ATMS
0001284150
CITRON SHIMON
3 ELIEZER VARDINON ST.
PETACH TIKVA
L3
4959507
ISRAEL
1
1
0
0
Chief Executive Officer
Common Stock
15665690
D
Common Stock
10443793
I
By Spouse
Series D Preferred Stock
Common Stock
32772000
D
Series D Preferred Stock
Common Stock
21848400
I
By Spouse
These securities are beneficially owned by Mr. Citron's spouse, Sigal Citron. Mr. Citron disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Upon the Issuer's increase of its authorized shares of Common Stock, expected in September 2022, all shares of Series D Preferred Stock will automatically convert into the Issuer's Common Stock.
The Series D Preferred Stock has no expiration date.
Each share of Series D Preferred Stock will convert into 600 shares of the Issuer's Common Stock.
/s/ Shimon Citron
2022-08-12